Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pickar

Showing results (91-100 of 268) with videos related to

Pageof 27
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 1999
The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia: evidence of a sex effectR M Cohen, T E Nordahl, W E Semple, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Cerebrospinal fluid neuropeptide Y in depression and schizophreniaW H Berrettini, A R Doran, J Kelsoe, et al.
Archives of General Psychiatry|October 24, 1997
D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patientsT P Su, A K Malhotra, K Hadd, et al.
Psychiatry Research|March 1, 1987
Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic functionA Roy, D Pickar, M Linnoila, et al.
Psychiatry Research|March 1, 1984
Prazosin, a specific alpha 1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patientsD W Hommer, T P Zahn, D Pickar, et al.
The American Journal of Psychiatry|November 1, 1990
Plasma norepinephrine in chronic schizophreniaA Breier, O M Wolkowitz, A Roy, et al.
Archives of General Psychiatry|April 1, 1986
Cerebrospinal fluid monoamine and monoamine metabolite levels and the dexamethasone suppression test in depression. Relationship to life eventsA Roy, D Pickar, M Linnoila, et al.
Psychopharmacology Bulletin|January 1, 1988
Metabolic stress effects in normal volunteers and schizophrenic patientsA Breier, O M Wolkowitz, M Rapaport, et al.
Schizophrenia Research|May 1, 1994
Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophreniaR E Litman, D W Hommer, A Radant, et al.
Psychiatry Research|August 1, 1988
Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteersA Breier, O M Wolkowitz, A R Doran, et al.
Pageof 27

Showing results (91-100 of 268) with videos related to

Sort By:
Pageof 27
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 1999
The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia: evidence of a sex effectR M Cohen, T E Nordahl, W E Semple, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Cerebrospinal fluid neuropeptide Y in depression and schizophreniaW H Berrettini, A R Doran, J Kelsoe, et al.
Archives of General Psychiatry|October 24, 1997
D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patientsT P Su, A K Malhotra, K Hadd, et al.
Psychiatry Research|March 1, 1987
Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic functionA Roy, D Pickar, M Linnoila, et al.
Psychiatry Research|March 1, 1984
Prazosin, a specific alpha 1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patientsD W Hommer, T P Zahn, D Pickar, et al.
The American Journal of Psychiatry|November 1, 1990
Plasma norepinephrine in chronic schizophreniaA Breier, O M Wolkowitz, A Roy, et al.
Archives of General Psychiatry|April 1, 1986
Cerebrospinal fluid monoamine and monoamine metabolite levels and the dexamethasone suppression test in depression. Relationship to life eventsA Roy, D Pickar, M Linnoila, et al.
Psychopharmacology Bulletin|January 1, 1988
Metabolic stress effects in normal volunteers and schizophrenic patientsA Breier, O M Wolkowitz, M Rapaport, et al.
Schizophrenia Research|May 1, 1994
Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophreniaR E Litman, D W Hommer, A Radant, et al.
Psychiatry Research|August 1, 1988
Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteersA Breier, O M Wolkowitz, A R Doran, et al.
Pageof 27